Representing RDD Pharma in a merger with a Nasdaq traded company

Partners Ofer Ben-Yehuda, Amir Iliescu and Doron Mutai & associates Daniel Kariv, Ofer Filhaber and Roni Lifshitz represented RDD Pharma in a merger transaction of the Nasdaq traded company Innovate Biopharmaceuticals Inc.; the new name of the merged company is 9 Merers Biopharma Inc.

In addition, a third company was also acquired and 22M USD was raised in new financing that was led by Orbimed Advisors, LLC.

Read the full article

Related News

Events

New Opportunities (Distress) in Israel

Read More
Events

Open Source Webinar with The ACC, Adv. Ido Shomroni

Read More
HIGH TECH

The current funding atmosphere, Adv. Ofer Ben-Yehuda at ICSI

Read More
HIGH TECH

VC Survey 2019, Occasionally reality exceeds any imagination

Read More
HIGH TECH

Open Source Webinar with The ACC, Adv. Ido Shomroni

Read More
HIGH TECH

Representing Bridges Israel in an investment of USD 5M

Read More